Literature DB >> 3915642

Stereotactic radiosurgery utilizing a linear accelerator.

F Colombo, A Benedetti, F Pozza, A Zanardo, R C Avanzo, G Chierego, C Marchetti.   

Abstract

The authors have developed a radiosurgical technique based on multiple arc irradiations. The target is fixed to the rotational isocenter of a Varian 4 MV linear accelerator. The first irradiation is carried out while the radiating source is rotating on a 100-140 degrees arc. The patient is then rotated around a vertical axis passing through the target, and arc irradiations are repeated in different angular positions. By this technique it is possible to obtain very steep dose gradients at the borders of the target volume. High doses are usually delivered in two shots. 47 patients have been treated so far in a clinical trial that started in November 1982. The paper deals with the preliminary results (more than 6 months' follow-up) obtained in patients affected by nonresectable brain tumors and AVMs.

Entities:  

Mesh:

Year:  1985        PMID: 3915642     DOI: 10.1159/000101117

Source DB:  PubMed          Journal:  Appl Neurophysiol


  10 in total

Review 1.  The evolution of stereotactic radiosurgery in neurosurgical practice.

Authors:  Daniel M Trifiletti; Henry Ruiz-Garcia; Alfredo Quinones-Hinojosa; Rohan Ramakrishna; Jason P Sheehan
Journal:  J Neurooncol       Date:  2021-02-21       Impact factor: 4.130

2.  Radiosurgery technology development and use.

Authors:  Sanford L Meeks; Jason Pukala; Naren Ramakrishna; Twyla R Willoughby; Francis J Bova
Journal:  J Radiosurg SBRT       Date:  2011

3.  Stereotactic radiosurgery: instrumentation and theoretical aspects-part 1.

Authors:  Joseph C T Chen; Michael R Girvigian
Journal:  Perm J       Date:  2005

4.  Outcome of cerebral arteriovenous malformations after linear accelerator reirradiation.

Authors:  Paulo L Moraes; Rodrigo S Dias; Eduardo Weltman; Adelmo J Giordani; Salomon Benabou; Helena R C Segreto; Roberto A Segreto
Journal:  Surg Neurol Int       Date:  2015-06-04

5.  Combination of needle aspiration and core needle biopsy: A new technique of stereotactic biopsy.

Authors:  Abrar Ahad Wani; M Afzal Wani; Altaf U Ramzan; Furqan A Nizami; Nayil K Malik; S Shafiq; Rais Ahmad; Ashish Kumar; Iqbal Lone; Rumana Makhdoomi
Journal:  Asian J Neurosurg       Date:  2016 Apr-Jun

6.  Optimization of dose distributions of target volumes and organs at risk during stereotactic body radiation therapy for pancreatic cancer with dose-limiting auto-shells.

Authors:  Yangsen Cao; Xiaofei Zhu; Xiaoping Ju; Yongming Liu; Chunshan Yu; Yongjian Sun; Zhitao Dai; Xueling Guo; Huojun Zhang
Journal:  Radiat Oncol       Date:  2018-01-22       Impact factor: 3.481

7.  Inverse treatment planning for spinal robotic radiosurgery: an international multi-institutional benchmark trial.

Authors:  Oliver Blanck; Lei Wang; Wolfgang Baus; Jimm Grimm; Thomas Lacornerie; Joakim Nilsson; Sergii Luchkovskyi; Isabel Palazon Cano; Zhenyu Shou; Myriam Ayadi; Harald Treuer; Romain Viard; Frank-Andre Siebert; Mark K H Chan; Guido Hildebrandt; Jürgen Dunst; Detlef Imhoff; Stefan Wurster; Robert Wolff; Pantaleo Romanelli; Eric Lartigau; Robert Semrau; Scott G Soltys; Achim Schweikard
Journal:  J Appl Clin Med Phys       Date:  2016-05-08       Impact factor: 2.102

Review 8.  Stereotactic radiosurgery (SRS) for brain metastases: a systematic review.

Authors:  Carsten Nieder; Anca L Grosu; Laurie E Gaspar
Journal:  Radiat Oncol       Date:  2014-07-12       Impact factor: 3.481

9.  Selection of external beam radiotherapy approaches for precise and accurate cancer treatment.

Authors:  Hiroki Shirato; Quynh-Thu Le; Keiji Kobashi; Anussara Prayongrat; Seishin Takao; Shinichi Shimizu; Amato Giaccia; Lei Xing; Kikuo Umegaki
Journal:  J Radiat Res       Date:  2018-03-01       Impact factor: 2.724

10.  Prospective analysis of different combined regimens of stereotactic body radiation therapy and chemotherapy for locally advanced pancreatic cancer.

Authors:  Xiaofei Zhu; Dongchen Shi; Fuqi Li; Xiaoping Ju; Yangsen Cao; Yuxin Shen; Fei Cao; Shuiwang Qing; Fang Fang; Zhen Jia; Huojun Zhang
Journal:  Cancer Med       Date:  2018-05-17       Impact factor: 4.452

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.